Emergent BioSolutions Inc. — Director's Dealing 2019

Dec 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2019-12-12

Reporting Person: Bailey Sue (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-12	Common Stock	S	8375	$53.46	Disposed	46333	Direct

Footnotes

F1: Consists of restricted stock units granted under the Company's stock incentive plan, as amended and restated.

F2: The price reported is the weighted average sale price. These shares were sold in multiple transactions in prices ranging from $53.08 to $53.82.